We are live on ! Find out more

32 hedge funds and large institutions have $2.96M invested in iBio in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

21% more capital invested

Capital invested by funds: $2.44M → $2.96M (+$511K)

7% more funds holding

Funds holding: 3032 (+2)

1.59% less ownership

Funds ownership: 19.75%18.16% (-1.6%)

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
8
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change

IBIO Hedge Fund Activity: Q3 2025 in Review

32 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2025, worth a combined $2.96M — up 21% from $2.44M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IBIO positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 6 trimmed.

The largest buyer was Ameriprise, opening a new position worth an estimated $371K. The largest seller was Lynx1 Capital Management, cutting an estimated $371K.

  • 32 institutional investors held iBio (IBIO) as of Q3 2025, up from 30 in Q2 2025.
  • Funds reported $2.96M of iBio stock for Q3 2025, up 21% quarter-over-quarter.
  • 6 funds opened new iBio positions in Q3 2025 and 3 closed out, a net change of +3 holders.
  • The largest iBio buyer in Q3 2025 was Ameriprise, an estimated $371K added.
  • The largest iBio seller in Q3 2025 was Lynx1 Capital Management, an estimated $371K sold.

Based on aggregated 13F filings for Q3 2025.